Search company, investor...

Predict your next investment

Curative company logo
Corporation
HEALTHCARE | Medical Equipment & Supplies
curative.com

Partners & Customers

10

About Curative

Curative is working to build alternate supply sources of many of the major sample collection and extraction kit components that use flocked cotton swabs, and scalable RNA extraction methods that do not rely on the supply-constrained magnetic silica beads. Its test can be self-administered at home with a 24-48 hour turnaround time between testing and results.

Headquarters Location

430 S Cataract Ave

San Dimas, California, 91773,

United States

Want to inform investors similar to Curative about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Curative News

FDA grants Curative request to revoke COVID-19 test EUA, company pivots to Abbott kits after false result risk

Jul 16, 2021

Published July 16, 2021 Dive Brief: FDA has revoked the emergency use authorization for Curative's COVID-19 test, at the request of the company, six months after the agency issued an alert about the risk of false results. The EUA was granted  to the Curative test in April 2020, making it one of the first COVID-19 kits cleared for use with saliva samples. However, by January 2021, FDA had concerns about false results potentially linked to sample collection. FDA said in a Thursday update to its safety communication on the test that the revocation, effective July 15, was requested by Curative "because the company is now using different EUA-authorized tests for the testing offered at its laboratories. " Curative is using its labs to process other tests, namely the Abbott Alinity m SARS-CoV-2 Assay and a CLIA-validated test based on the CDC SARS-CoV-2 multiplex assay. Dive Insight: The introduction of the Curative test, which was brought to market in collaboration with KorvaLabs, was hailed as a win in the effort to scale up U.S. diagnostic capacity after a slow start early in the pandemic. Curative designed the test for use with swabs or oral fluid specimens. With swabs in short supply early in the crisis, the saliva option removed one bottleneck to testing. Curative was reportedly processing 150,000 COVID-19 saliva samples a day by January 2021, less than one year after it was founded as a sepsis startup. The company's pivot to COVID-19 helped Los Angeles and other U.S. cities including Seattle scale up their testing capacity. However, the test at the heart of the operation is now off the market. At the request of Curative, FDA revoked the EUA on Thursday. "The test that is the subject of this safety communication is no longer being offered and is no longer authorized for emergency use by the FDA," the agency said in Thursday's announcement. The FDA notice comes one month after Curative disclosed a partnership with Abbott. The agreement positioned Curative to offer the Alinity m SARS-CoV-2 Assay from early July. Curative also secured access to Abbott's Alinity m Resp-4-Plex, equipping it to test for SARS-CoV-2, Flu A, Flu B, and RSV in one kit. In a statement, Curative said it will use the Alinity m SARS-CoV-2 Assay to detect the coronavirus in nasal swabs self-collected at a healthcare location. Curative also used a CLIA-validated test based on the CDC SARS-CoV-2 multiplex assay to test for the virus in upper or lower respiratory specimens. The portfolio of kits equips Curative to test asymptomatic and symptomatic people and run pooled tests. The Abbott deal also positions Curative to test for multiple respiratory pathogens that can manifest in similar symptoms but need treating differently. The feared simultaneous waves of SARS-CoV-2 and influenza never materialized last winter but there are concerns for this season and there is already evidence of rising cases of respiratory syncytial virus. Curative said that it made the decision to discontinue its PCR COVID-19 test and asked the FDA to revoke the EUA "as it is no longer needed" with a suite of new testing offerings for patients at its 15,000 sites in more than 20 states.

Curative Acquisitions

1 Acquisition

Curative acquired 1 company. Their latest acquisition was KorvaLabs on May 19, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/19/2020

$99M

Acquired

3

Date

5/19/2020

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

3

Curative Partners & Customers

10 Partners and customers

Curative has 10 strategic partners and customers. Curative recently partnered with Latino Leadership on November 11, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

11/18/2022

Partner

United States

Our Commitment to the Hispanic and Latinx Community.

Curative 's partnership with Latino Leadership , Inc. has provided testing for the Orlando community .

1

4/4/2022

Partner

United States

06:00 EDT COVID-19 Testing Leader Curative Announces Partnership with Truepill for Easy Access to Telehealth Consults and COVID-...

SAN DIMAS , Calif. , April 4 , 2022 / PRNewswire / -- COVID-19 testing and next-generation healthcare delivery company Curative and Truepill , the digital health platform connecting telehealth , diagnostics , and pharmacy to power the future of consumer healthcare , today announced a partnership to give patients ' who test positive at a Curative testing site easy access to next day antiviral treatment options .

1

2/7/2022

Partner

United States

Longwood Partners with Covid-19 Testing Company for Community Tests. Longwood Partners with Covid-19 Testing Company - Longwood University

Longwood University has partnered with Curative , a medical testing company , to provide Covid-19 tests to the campus , Farmville and Southside communities with no out-of-pocket costs , the university announced Monday .

1

1/6/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

7/28/2021

Client

United States

Subscribe to see more

Subscribe to see more

10

Date

11/18/2022

4/4/2022

2/7/2022

1/6/2022

7/28/2021

Type

Partner

Partner

Partner

Partner

Client

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Our Commitment to the Hispanic and Latinx Community.

Curative 's partnership with Latino Leadership , Inc. has provided testing for the Orlando community .

06:00 EDT COVID-19 Testing Leader Curative Announces Partnership with Truepill for Easy Access to Telehealth Consults and COVID-...

SAN DIMAS , Calif. , April 4 , 2022 / PRNewswire / -- COVID-19 testing and next-generation healthcare delivery company Curative and Truepill , the digital health platform connecting telehealth , diagnostics , and pharmacy to power the future of consumer healthcare , today announced a partnership to give patients ' who test positive at a Curative testing site easy access to next day antiviral treatment options .

Longwood Partners with Covid-19 Testing Company for Community Tests. Longwood Partners with Covid-19 Testing Company - Longwood University

Longwood University has partnered with Curative , a medical testing company , to provide Covid-19 tests to the campus , Farmville and Southside communities with no out-of-pocket costs , the university announced Monday .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Curative Team

8 Team Members

Curative has 8 team members, including current Chief Executive Officer, Jeffrey Bowling.

Name

Work History

Title

Status

Jeffrey Bowling

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Jeffrey Bowling

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.